General Information of This Payload
Payload ID
PAY0HRCYR
Name
Payload 4574
Synonyms
4574
   Click to Show/Hide
Structure
Formula
C29H54N4O7
Isosmiles
C[C@H]([C@H](N(C)C([C@@H](NC(C(C)(N(C)C)C)=O)C(C)C)=O)[C@H](OC)CC(N1CCC[C@H]1[C@H](OC)CC(O)=O)=O)CC
InChI
InChI=1S/C29H54N4O7/c1-12-19(4)26(32(9)27(37)25(18(2)3)30-28(38)29(5,6)31(7)8)22(40-11)16-23(34)33-15-13-14-20(33)21(39-10)17-24(35)36/h18-22,25-26H,12-17H2,1-11H3,(H,30,38)(H,35,36)/t19-,20-,21+,22+,25-,26-/m0/s1
InChIKey
MNINXXHXSQWYFB-REQDVVOUSA-N
Pharmaceutical Properties
Molecule Weight
570.772
Polar area
128.72
Complexity
818.976375
xlogp Value
2.2263
Heavy Count
40
Rot Bonds
16
Hbond acc
7
Hbond Donor
2
The activity data of This Payload
Standard Type Value Units Cell line Disease Model Cell line ID Reference
Half maximal Inhibitory Concentration (IC50) 3.54 nM
WI38-VA13 cells
Normal
CVCL_2759 
[1]
Half maximal Inhibitory Concentration (IC50) 3.54 nM
WI38-VA13 cells
Normal
CVCL_2759 
[1]
Half maximal Inhibitory Concentration (IC50) 3.65 nM
HT29 cells
Colon cancer
CVCL_A8EZ 
[1]
Half maximal Inhibitory Concentration (IC50) 3.65 nM
HT29 cells
Colon cancer
CVCL_A8EZ 
[1]
Each Antibody-drug Conjugate Related to This Payload
Full Information of The Activity Data of The ADC(s) Related to This Payload
EDB-diS-L19-4574 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 2 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
429 ng/mL
Negative EDB expression (EDB-)
Method Description
Calculated using four-parameter logistic model #203 with XLfit v4.8 (IDBS)
In Vitro Model Colon cancer HT29 cells CVCL_A8EZ
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
487 ng/mL
Positive EDB expression (EDB+++/++)
Method Description
Calculated using four-parameter logistic model #203 with XLfit v4.7 (IDBS)
In Vitro Model Normal WI38-VA13 cells CVCL_2759
References
Ref 1 Anti-EDB antibodies and antibody-drug conjugates